Cargando…
Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis
Carbapenem-resistant Enterobacteriaceae (CRE) infections are prevalent worldwide; they have few effective treatments and this jeopardizes public health. Clinicians often use tigecycline to combat CRE, but its clinical efficacy remains controversial. Therefore, to compare the efficacy and safety of t...
Autores principales: | Ni, Wentao, Han, Yuliang, Liu, Jie, Wei, Chuanqi, Zhao, Jin, Cui, Junchang, Wang, Rui, Liu, Youning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839946/ https://www.ncbi.nlm.nih.gov/pubmed/26986165 http://dx.doi.org/10.1097/MD.0000000000003126 |
Ejemplares similares
-
Efficacy of polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis
por: Ni, Wentao, et al.
Publicado: (2015) -
Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae
por: Ni, Wentao, et al.
Publicado: (2016) -
High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A retrospective cohort study
por: Geng, Ting-Ting, et al.
Publicado: (2018) -
Carbapenems vs tigecycline for the treatment of complicated intra-abdominal infections: A Bayesian network meta-analysis of randomized clinical trials
por: Chen, Lingyuan, et al.
Publicado: (2019) -
Efficacy and safety of high-dose tigecycline for the treatment of infectious diseases: A meta-analysis
por: Gong, Jinhong, et al.
Publicado: (2019)